GINA SLOBOGIN: Open Payments
NPI 1639625809 · UPPER CHICHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,933 in 137 payments from 35 companies in 2025. Trend: 2023 $3,287 · 2024 $2,706 · 2025 $2,933
Food & beverage: $2,733Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $323 |
| Axsome Therapeutics, Inc. | 10 | $219 |
| Alkermes, Inc. | 8 | $217 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $200 |
| ABBVIE INC. | 11 | $195 |
| Otsuka America Pharmaceutical, Inc. | 10 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $121 |
| Ardelyx, Inc. | 5 | $110 |
| Indivior Inc. | 5 | $109 |
| Gebauer Company | 1 | $107 |
Products named: LYBALVI, LUMRYZ, REXULTI, CAPLYTA, Sunosi, IBSRELA, SUBLOCADE, FREESTYLE LIBRE 3.
Industry payments across PA — which companies pay providers there.
